Lilium (LILM) Stock Forecast, Price Target & Predictions
LILM Stock Forecast
Lilium stock forecast is as follows: an average price target of $3.50 (represents a 348.72% upside from LILM’s last price of $0.78) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.
LILM Price Target
The average price target for Lilium (LILM) is $3.50 based on 1-year price targets from 14 Wall Street analysts in the past 3 months, with a price target range of $5.00 to $2.00. This represents a potential 348.72% upside from LILM's last price of $0.78.
LILM Analyst Ratings
According to 14 Wall Street analysts, Lilium's rating consensus is 'Buy'. The analyst rating breakdown for LILM stock is 0 'Strong Buy' (0.00%), 8 'Buy' (57.14%), 6 'Hold' (42.86%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Lilium Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 19, 2024 | Andres Sheppard | Cantor Fitzgerald | $2.00 | $0.98 | 104.71% | 156.41% |
| May 28, 2024 | Austin Moeller | Canaccord Genuity | $2.00 | $0.91 | 118.91% | 156.41% |
| Jul 14, 2023 | Austin Moeller | Canaccord Genuity | $3.00 | $1.32 | 127.27% | 284.62% |
| Apr 28, 2022 | - | J.P. Morgan | $5.00 | $3.10 | 61.29% | 541.03% |
| Apr 19, 2022 | - | Barclays | $5.00 | $3.71 | 34.81% | 541.03% |
The latest Lilium stock forecast, released on Jul 19, 2024 by Andres Sheppard from Cantor Fitzgerald, set a price target of $2.00, which represents a 104.71% increase from the stock price at the time of the forecast ($0.98), and a 156.41% increase from LILM last price ($0.78).
Lilium Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 2 |
| Avg Price Target | - | $2.00 | $2.00 |
| Last Closing Price | $0.78 | $0.78 | $0.78 |
| Upside/Downside | -100.00% | 156.41% | 156.41% |
In the current month, the average price target of Lilium stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Lilium's last price of $0.78. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 19, 2024 | Cantor Fitzgerald | - | Overweight | Initialise |
| May 28, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Jul 17, 2023 | Stephens | - | Overweight | Upgrade |
| Jul 17, 2023 | Jefferies | - | Buy | Upgrade |
| Jul 17, 2023 | Morgan Stanley | - | Equal-Weight | Downgrade |
| Jul 17, 2023 | B. Riley Securities | - | Buy | Upgrade |
| Jul 17, 2023 | Barclays | - | Equal-Weight | Downgrade |
| Jul 17, 2023 | Raymond James | - | Market Perform | Downgrade |
| Jul 17, 2023 | UBS | - | Neutral | Downgrade |
| Jul 17, 2023 | Citigroup | - | Neutral | Downgrade |
Lilium's last stock rating was published by Cantor Fitzgerald on Jul 19, 2024. The company Initialise its LILM rating from "null" to "Overweight".
Lilium Financial Forecast
Lilium Revenue Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $-35.25K |
| Avg Forecast | - | - | - | - | - | $-24.66K | $-27.78K | $-31.29K | $-35.25K |
| High Forecast | - | - | - | - | - | $-24.66K | $-27.78K | $-31.29K | $-35.25K |
| Low Forecast | - | - | - | - | - | $-24.66K | $-27.78K | $-31.29K | $-35.25K |
| # Analysts | 3 | 2 | 2 | 4 | 3 | 2 | 2 | 2 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | 1.00% |
Lilium's average Quarter revenue forecast for Mar 23 based on 2 analysts is $-31.29K, with a low forecast of $-31.29K, and a high forecast of $-31.29K. LILM's average Quarter revenue forecast represents a -11.23% decrease compared to the company's last Quarter revenue of $-35.25K (Dec 22).
Lilium EBITDA Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 2 | 2 | 4 | 3 | 2 | 2 | 2 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | $303.40M |
| Avg Forecast | - | - | - | - | - | $-4.93K | $-5.56K | $-6.26K | $-7.05K |
| High Forecast | - | - | - | - | - | $-4.93K | $-5.56K | $-6.26K | $-7.05K |
| Low Forecast | - | - | - | - | - | $-4.93K | $-5.56K | $-6.26K | $-7.05K |
| Surprise % | - | - | - | - | - | - | - | - | -43041.96% |
2 analysts predict LILM's average Quarter EBITDA for Mar 23 to be $-6.26K, with a high of $-6.26K and a low of $-6.26K. This is -100.00% lower than Lilium's previous annual EBITDA (Dec 22) of $303.40M.
Lilium Net Income Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 2 | 2 | 4 | 3 | 2 | 2 | 2 | 1 |
| Net Income | - | - | - | - | - | - | - | - | $308.28M |
| Avg Forecast | $-108.83M | $-110.97M | $-110.97M | $-116.97M | $-104.64M | $-56.81M | $-47.42M | $-65.10M | $-60.07M |
| High Forecast | $-108.83M | $-110.97M | $-110.97M | $-116.97M | $-104.64M | $-56.81M | $-47.42M | $-65.10M | $-60.07M |
| Low Forecast | $-108.83M | $-110.97M | $-110.97M | $-116.97M | $-104.64M | $-56.81M | $-47.42M | $-65.10M | $-60.07M |
| Surprise % | - | - | - | - | - | - | - | - | -5.13% |
Lilium's average Quarter net income forecast for Mar 23 is $-65.10M, with a range of $-65.10M to $-65.10M. LILM's average Quarter net income forecast represents a -121.12% decrease compared to the company's last Quarter net income of $308.28M (Dec 22).
Lilium SG&A Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 2 | 2 | 4 | 3 | 2 | 2 | 2 | 1 |
| SG&A | - | - | - | - | - | - | - | - | $177.58M |
| Avg Forecast | - | - | - | - | - | $-29.08M | $-32.76M | $-36.90M | $-41.56M |
| High Forecast | - | - | - | - | - | $-29.08M | $-32.76M | $-36.90M | $-41.56M |
| Low Forecast | - | - | - | - | - | $-29.08M | $-32.76M | $-36.90M | $-41.56M |
| Surprise % | - | - | - | - | - | - | - | - | -4.27% |
Lilium's average Quarter SG&A projection for Mar 23 is $-36.90M, based on 2 Wall Street analysts, with a range of $-36.90M to $-36.90M. The forecast indicates a -120.78% fall compared to LILM last annual SG&A of $177.58M (Dec 22).
Lilium EPS Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 2 | 2 | 4 | 3 | 2 | 2 | 2 | 1 |
| EPS | - | - | - | - | - | - | - | - | $0.78 |
| Avg Forecast | $-0.16 | $-0.17 | $-0.17 | $-0.18 | $-0.16 | $-0.14 | $-0.12 | $-0.17 | $-0.15 |
| High Forecast | $-0.16 | $-0.17 | $-0.17 | $-0.18 | $-0.16 | $-0.14 | $-0.12 | $-0.17 | $-0.15 |
| Low Forecast | $-0.16 | $-0.17 | $-0.17 | $-0.18 | $-0.16 | $-0.14 | $-0.12 | $-0.17 | $-0.15 |
| Surprise % | - | - | - | - | - | - | - | - | -5.11% |
According to 2 Wall Street analysts, Lilium's projected average Quarter EPS for Mar 23 is $-0.17, with a low estimate of $-0.17 and a high estimate of $-0.17. This represents a -121.22% decrease compared to LILM previous annual EPS of $0.78 (Dec 22).
Lilium Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| LILM | Lilium | $0.78 | $3.50 | 348.72% | Buy |
| DPRO | Draganfly | $2.47 | $7.00 | 183.40% | Buy |
| EVTL | Vertical Aerospace | $0.88 | $2.38 | 170.45% | Buy |
| EVEX | Eve | $2.87 | $6.75 | 135.19% | Buy |
| SPCE | Virgin Galactic | $6.99 | $15.88 | 127.18% | Hold |
| EH | EHang | $12.15 | $21.75 | 79.01% | Buy |
| ACHR | Archer Aviation | $3.31 | $5.75 | 73.72% | Buy |
| PL | Planet Labs PBC | $2.15 | $3.67 | 70.70% | Buy |
| LUNR | Intuitive Machines | $6.13 | $9.75 | 59.05% | Buy |
| RDW | Radware | $6.49 | $8.13 | 25.27% | Buy |
| RKLB | Rocket Lab USA | $7.46 | $7.31 | -2.01% | Buy |
| HEI | HEICO | $259.35 | $243.80 | -6.00% | Buy |
LILM Forecast FAQ
Is Lilium a good buy?
Yes, according to 14 Wall Street analysts, Lilium (LILM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 8 'Buy' recommendations, accounting for 57.14% of LILM's total ratings.
What is LILM's price target?
Lilium (LILM) average price target is $3.5 with a range of $2 to $5, implying a 348.72% from its last price of $0.78. The data is based on 14 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Lilium stock go up soon?
According to Wall Street analysts' prediction for LILM stock, the company can go up by 348.72% (from the last price of $0.78 to the average price target of $3.5), up by 541.03% based on the highest stock price target, and up by 156.41% based on the lowest stock price target.
Can Lilium stock reach $1?
LILM's average twelve months analyst stock price target of $3.5 supports the claim that Lilium can reach $1 in the near future.
What are Lilium's analysts' financial forecasts?
Lilium's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $-83.737K (high $-83.737K, low $-83.737K), average EBITDA is $-16.746K (high $-16.746K, low $-16.746K), average net income is $-274M (high $-274M, low $-274M), average SG&A $-98.733M (high $-98.733M, low $-98.733M), and average EPS is $-0.589 (high $-0.589, low $-0.589). LILM's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-448M (high $-448M, low $-448M), average SG&A $0 (high $0, low $0), and average EPS is $-0.677 (high $-0.677, low $-0.677).
Did the LILM's actual financial results beat the analysts' financial forecasts?
In terms of the last quarterly report (Dec 2022), Lilium's revenue was $-35.25K, beating the average analysts' forecast of $-35.25K by 0%. The company's EBITDA was $303.4M, missing the average prediction of $-7.049K by -4304295.63%. Lilium's net income was $308.28M, missing the average estimation of $-60.074M by -613.16%. The company's SG&A was $177.58M, missing the average forecast of $-41.563M by -527.25%. Lastly, the company's EPS was $0.78, missing the average prediction of $-0.153 by -610.64%